---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-068696"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:36:22.544215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical stockholders approve tripling of equity plan shares and warrant issuance to institutional investor

## Summary
- Elected directors Collins, Baird, Vincent with >25M votes each; no director received majority against.
- Approved amendment to 2022 Omnibus Plan increasing authorized shares from 3,278,457 to 9,778,457.
- Approved issuance of 20%+ of outstanding shares upon exercise of Series A (10.8M) and Series B (5.4M) warrants to a single institutional investor.
- Ratified WithumSmith+Brown as independent auditor for FY2024 with 44.6M for, 1.8M against.

## SEC filing metadata
- accession: 0000950170-24-068696
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017024068696/0000950170-24-068696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017024068696/icu-20240604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-068696
- JSON: https://secwatch.observer/filing/0000950170-24-068696.json
- Plain text: https://secwatch.observer/filing/0000950170-24-068696.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.